Fortis Capital Management’s ResMed RMD Stock Holding History

Fortis Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.6M	Buy	28,722 +34	+0.1%	+$7.05K	0.63%	44
2026 Q1	$6.44M	Buy	28,688 +687	+2%	+$171K	0.66%	35
2025 Q4	$6.74M	Buy	28,001 +2,060	+8%	+$527K	0.89%	36
2025 Q3	$7.1M	Buy	25,941 +1,476	+6%	+$403K	1%	29
2025 Q2	$6.31M	Buy	24,465 +1,293	+6%	+$308K	0.98%	33
2025 Q1	$5.19M	Buy	+23,172	New	+$5.41M	1.01%	28
2021 Q2	–	Sell	-10,618	Closed	-$2.06M	–	129
2021 Q1	$2.06M	Buy	+10,618	New	+$2.13M	1.19%	33
2020 Q4	–	Sell	-12,450	Closed	-$2.13M	–	123
2020 Q3	$2.13M	Buy	+12,450	New	+$2.3M	1.69%	7

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fortis Capital Management's RMD Position: Q2 2026 in Review

Fortis Capital Management increased its ResMed (RMD) stake by 0.12% in Q2 2026, buying an estimated $7.05K and bringing the position to 28,722 shares worth $5.6M. The position accounts for 0.63% of the portfolio, ranked #44.

Fortis Capital Management first reported a position in RMD in Q3 2020 and has held it in 8 quarters since. The position peaked at $7.1M in Q3 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Fortis Capital Management held 28,722 shares of ResMed worth $5.6M as of Q2 2026.
Fortis Capital Management bought 34 ResMed shares in Q2 2026, an estimated $7.05K.
ResMed made up 0.63% of Fortis Capital Management's portfolio in Q2 2026, its #44 holding.
Fortis Capital Management first reported a position in ResMed in Q3 2020 and has held it in 8 quarters since.
Fortis Capital Management's ResMed position peaked at $7.1M in Q3 2025.
880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Fortis Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.